Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Biotricity Inc. (BTCY : OTC)
 
 • Company Description   
Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.42 Daily Weekly Monthly
20 Day Moving Average: 40,735 shares
Shares Outstanding: 24.91 (millions)
Market Capitalization: $10.47 (millions)
Beta: 1.11
52 Week High: $1.01
52 Week Low: $0.19
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.98% -23.54%
12 Week 0.24% -14.38%
Year To Date 44.91% 35.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
203 Redwood Shores Parkway Suite 600
-
REDWOOD CITY,CA 94065
USA
ph: 650-832-1626
fax: -
investors@biotricity.com http://www.biotricity.com
 
 • General Corporate Information   
Officers
Waqaas Al-Siddiq - Chairman; President and Chief Executive Officer
John Ayanoglou - Chief Financial Officer
David A. Rosa - Director
Ron McClurg - Director
Chester White - Director

Peer Information
Biotricity Inc. (HLIS)
Biotricity Inc. (AZTA)
Biotricity Inc. (APYI)
Biotricity Inc. (RNVA)
Biotricity Inc. (HMSY)
Biotricity Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 09074H203
SIC: 3841
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/24
Next Expected EPS Date: 08/18/25
Share - Related Items
Shares Outstanding: 24.91
Most Recent Split Date: 7.00 (0.17:1)
Beta: 1.11
Market Capitalization: $10.47 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.39 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/18/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.79
EPS Growth
vs. Year Ago Period: 85.29%
vs. Previous Quarter: 28.57%
Sales Growth
vs. Year Ago Period: 21.73%
vs. Previous Quarter: 10.77%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -188.47
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.23
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.16
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -80.42
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -80.42
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -80.42
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -1.30
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 1.90
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©